Full Breakdown
Understanding Cannabinoid Hyperemesis Syndrome: The Rise of "Scromiting"
12/10/2025, 3:13:00 AM
Overview of Cannabinoid Hyperemesis Syndrome
A recent study from the University of Illinois Chicago has confirmed the existence and increasing prevalence of Cannabinoid Hyperemesis Syndrome (CHS), colloquially known as "scromiting," a term derived from the combination of screaming and vomiting. CHS primarily affects heavy cannabis users, leading to severe nausea, abdominal pain, and violent vomiting episodes that can last up to two days. The only effective long-term solution identified so far is the cessation of all cannabis use.
Study Findings and Trends
The research, published in JAMA Network Open, analyzed a national database of emergency department visits from 2016 to 2022, identifying approximately 100,000 suspected cases of CHS. While the rates of CHS remained low and steady prior to 2020, there was a notable spike in cases during that year, coinciding with increased cannabis consumption likely driven by the COVID-19 pandemic. By 2022, the number of cases began to decline but did not return to pre-2020 levels.
Medical Recognition and Treatment
CHS has recently been recognized as an official diagnosis in the International Classification of Diseases, which may improve awareness among healthcare professionals. Despite its recognition, CHS is often misdiagnosed, leading to unnecessary medical tests. The primary treatment for CHS involves recognizing the syndrome and advising patients to stop using cannabis.
Criticism & Opposition
Some medical professionals express concern that the rise in CHS cases may be underreported due to the stigma surrounding cannabis use. Critics argue that the medical community needs to enhance its understanding of CHS to prevent misdiagnosis and ensure proper treatment. There is also a call for more research into the long-term effects of cannabis use and the mechanisms behind CHS.
Official Statements & Responses
The researchers emphasized the importance of recognizing CHS as a legitimate medical condition. They noted, “The good news is that CHS is treatable once it’s recognized,” highlighting the need for increased awareness among medical practitioners to avoid misdiagnosis.
Verbatim Quotes
- “Episodes can last up to two days.” — University of Illinois Chicago Researcher
- “Hot showers seem to be the only reliable form of short-term relief, and a lot of them.” — University of Illinois Chicago Researcher
- “Hopefully, that era is now over, as CHS is officially included in the International Classification of Diseases.” — University of Illinois Chicago Researcher
What's Next
As awareness of Cannabinoid Hyperemesis Syndrome grows, further research is anticipated to explore its causes and long-term implications for cannabis users. Medical professionals are encouraged to stay informed about CHS to improve diagnosis and treatment outcomes for affected individuals.
